Drugs / Viaskin Milk
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial · 1 missed | ||||||
| Phase 1/2 | NCT02223182 | Nov 2014 → Dec 2017 | food allergy | DBV Technologies | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02579876 Comparator | Oct 2015 → Dec 2017 | eosinophilic esophagitis, food allergy | Children's Hospital of Philadelphia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Viaskin Milk | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02579876 ↗ |
| Modality | Protein / enzyme biologic | “patch containing 150 mcg cow's milk proteins” NCT02223182 ↗ |
| Route | Other | “Subjects epicutaneously administered daily (up to 24 hours application per day) with a patch containing 150 mcg cow's milk proteins” NCT02223182 ↗ |